ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1210

Optimal Definitions of Worsening Cartilage Using Sequential MRI OsteoArthritis Knee Scores (MOAKS)

Kathryn Bacon1, mike LaValley2, Tuhina Neogi3, Ali Guermazi3, Frank Roemer3, Neil Segal4, Cora Lewis5, Michael Nevitt6, David Felson7 and John Lynch8, 1Boston University, Webster, NH, 2Boston University School of Public Health, Arlington, MA, 3Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 4University of Kansas, Kansas City, KS, 5University of Alabama at Birmingham, Birmingham, AL, 6University of California, San Francisco, San Francisco, CA, 7Boston University, Boston, MA, 8UCSF, San Francisco, CA

Meeting: ACR Convergence 2024

Keywords: cartilage, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The MRI OsteoArthritis Knee Score (MOAKS) is increasingly used in studies of knee osteoarthritis.  Our aim was to evaluate methods using MOAKS scores to define cartilage worsening outcomes, along with  established OA risk factors, to determine optimal approaches for future analyses of cartilage worsening in MOST.

Methods: Participants were from the Multicenter Osteoarthritis Study (MOST) with MOAKS readings from a baseline and follow-up exam 2 years later. MOAKS scores articular cartilage in 14 subregions across the knee in 2 dimensions: area of loss as % of subregion surface (AREA); and % of subregion that has full-thickness loss (FTL). AREA and FTL are scored as 0: None; 1: < 10%; 2: 10-75%; 3: >75%. MRIs were scored in chronological order, including within-grade changes for definite visual change that do not fulfill criteria of a full grade change. Our primary methods for creating MOAKS outcomes include: summing the AREA and FTL across subregions for a whole-knee 0-84 score; summing AREA and 2*FTL across subregions to emphasize FTL in the score; and using an increase in AREA or FTL within a subregion for 14 subregion-specific binary scores within the knee. Within-grade values were included.

Linear regression outcomes were evaluated in 3 ways: follow-up value as outcome adjusted for the baseline value; change in value as the outcome (follow-up – baseline) unadjusted for the baseline value; and change in value as outcome adjusted for the baseline value. Table 2 lists the outcome measures, including the region represented, whether change and baseline adjustment are included, and the regression model combinations to be considered (linear; binary logistic; negative binomial).To determine the optimal outcome, strengths of association with several predictors are calculated: body mass index (BMI); knee pain on a visual analog scale (VAS); total WOMAC; and hip-to knee alignment (HKA). Predictors were measured at baseline; age and sex are included as covariates in all models. For all analyses, the strength of association is measured by the regression estimate divided by its standard error (z score).

Results: We included 1852 MOST study participants with sequential MOAKS readings predictor and covariate values for 1 knee per participant; 25956 subregions across all knees. Z scores for association ranged from -2.28 to 6.17. The only outcome strongly associating with HKA used binary outcomes restricted to tibiofemoral lateral compartment. The overall strongest associations with predictors were in models using changes in MOAKS values without adjustment for the baseline value. The strongest associations were found for the outcome with binary subregional values including within-grade changes with GEE binary logistic regression and then the count of number of subregions worsened with negative binomial regression.

Conclusion: Outcomes for worsening cartilage based on MOAKS scores that performed the best used the changes in scores from baseline to 2-year follow-up without adjustment for baseline scores. The best outcome measure used binary worsening scores for an increase in either AREA or FTL in a subregion for 14-subregion-specific binary scores within the knee,  accounting for within-grade increases.

Supporting image 1

Table 1. Descriptive Characteristics of Study Participants

Supporting image 2

Table 2. Worsening Outcome Definitions and Associations with Predictors


Disclosures: K. Bacon: None; m. LaValley: None; T. Neogi: Amgen, 2, Eli Lilly, 2, GlaxoSmithKlein(GSK), 2, Novartis, 2, Sobi, 2; A. Guermazi: None; F. Roemer: None; N. Segal: Arthrex, 1, Pacira Biosciences, 2, 5, 6, Trice Medical, 6; C. Lewis: None; M. Nevitt: None; D. Felson: None; J. Lynch: None.

To cite this abstract in AMA style:

Bacon K, LaValley m, Neogi T, Guermazi A, Roemer F, Segal N, Lewis C, Nevitt M, Felson D, Lynch J. Optimal Definitions of Worsening Cartilage Using Sequential MRI OsteoArthritis Knee Scores (MOAKS) [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/optimal-definitions-of-worsening-cartilage-using-sequential-mri-osteoarthritis-knee-scores-moaks/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/optimal-definitions-of-worsening-cartilage-using-sequential-mri-osteoarthritis-knee-scores-moaks/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology